Participation of the Ukrainian company Ozymuk Pharm in the VIII International Congress "Innovative technologies in gynecology, mammology and aesthetic medicine"

November 18, 2022 Ukrainian company Ozymuk Pharm took part in the VIII International Congress "Innovative technologies in gynecology, mammology and aesthetic medicine". More than 1000 practicing gynecologists, obstetrician-gynecologists and mammologists listened to the reports of leading experts from Germany and Ukraine.

Particularly noteworthy is the report of Vasily Alekseevich Benyuk, Doctor of Medical Sciences, Professor, Head of the Department of Obstetrics and Gynecology No. 3, Honored Worker of Science and Technology, and a report on the topic “Prevention of recurrence of endometrial hyperplastic processes in premenopause . Modern view ", which states that "the inclusion of the drug Depapilin in the basic therapy of endometrial hyperplasia in women of premenopausal age is pathogenetically justified due to the complex effect of the components of the drug on extragonadal estrogen synthesis."

Ukrainian company Ozymuk Pharm is involved in cutting-edge research to address the recurrence of endometrial hyperplastic processes.